Преклапање поремећаја преједања и поремећаја употребе супстанци: Дијагноза и неуробиологија (КСНУМКС)

Ait-Daoud, N., Roache, J. D., Dawes, M. A., Liu, L., Wang, X-Q., Javors, M. A., Seneviratne, C. & Johnson, B. A. (2009): Can serotonin transporter genotype predict craving in alcoholism? Alcohol Clinical Experimental Research, 33(КСНУМКС), КСНУМКС-КСНУМКС.

Alger, S. A., Schwalberg, M. D., Bigaouette, J. M., Michalek, A. V. & Howard, L. J. (1991): Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normo-weight bulimic and obese, binge-eating subjects. The American Journal of Clinical Nutrition, 53(КСНУМКС), КСНУМКС-КСНУМКС.

American Psychiatric Association (2013): Дијагностички и статистички приручник о менталним поремећајима (5th ed.). Arlington, VA: Author.

Anderson, J. W., Greenway, F. L., Fuijoka, K., Gadde, K. M., McKenney, J. & O’Neil, P. M. (2002): Bupropion SR enhances weight loss: A 28-week double-blind, placebo-controlled trial. Obesity Research, 10(КСНУМКС), КСНУМКС-КСНУМКС.

Arbaizar, B., Dierssen-Sotos, T., Gómez-Acebo, I. & Llorca J. (2010): Topiramate in the treatment of alcohol dependence: A meta-analysis. Actas Españolas de Psiquiatria, 38, КСНУМКС-КСНУМКС.

Asin, K. E., Davis, J. D. & Bednarz, L. (1992): Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior. Psychopharmocology (Berlin), 109, КСНУМКС-КСНУМКС.

Avena, N. M., Rada, P. & Hoebel, B. G. (2008): Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neuroscience Biobehavioral Review, 31, КСНУМКС-КСНУМКС.

Avena, N. M., Rada, P. & Hoebel, B. G. (2009): Sugar and fat binging have notable differences in addictive-like behavior. The Journal of Nutrition, 139(КСНУМКС), КСНУМКС-КСНУМКС.

Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X. C., Toda, S. & Kalivas, P. W. (2003): Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Неуронаука, 6, КСНУМКС-КСНУМКС.

Balodis, I. M., Molina, N. D., Kober, H., Worhunsky, P. D., White, M. A., Sinha, R., Grilo, C. M. & Potenza, M. N. (2013): Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity. Obesity, 21(КСНУМКС), КСНУМКС-КСНУМКС.

Brody, A. L., Mandelkern, M. A., Lee, G., Smith, E., Sadeghi, M., Saxena, S., Jarvik, M. E. & London, E. D. (2004): Attenuation of cue-included cigarette craving and anterior cingulate cortex activation in bupropion treated smokers: A preliminary study. Психијатријска истраживања, 130, КСНУМКС-КСНУМКС.

Bulik, C. M., Sullivan, P. F. & Kendler, K. S. (2002): Medical and psychiatric morbidity in obese women with and without binge eating. The International Journal of Eating Disorders, 32(КСНУМКС), КСНУМКС-КСНУМКС.

Cambridge, V. C., Ziauddeen, H., Nathan, P. J., Subramaniam, N., Dodds, C., Chamberlain, S. R., Koch, A., Maltby, K., Skeggs, A. L., Napolitano, A., Farooqi, I. S., Bullmore, E. T. & Fletcher, P. C. (2013): Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Биолошка психијатрија, КСНУМКС, КСНУМКС-КСНУМКС.

Cassin, S. E. & von Ranson, K. M. (2007): Is binge eating experienced as an addiction? Аппетите, КСНУМКС(КСНУМКС), КСНУМКС-КСНУМКС.

Chamberlain, S. R., Mogg, K., Bradley, B. P., Koch, A., Dodds, C. M., Tao, W. X., Maltby, K., Sarai, B., Napolitano, A., Richards, D. B., Bullmore, E. T. & Nathan, P. J. (2012): Effects of mu opioid receptor antagonism on cognition in obese bingeeating individuals. Psychopharmacology (Berlin), 224(КСНУМКС), КСНУМКС-КСНУМКС.

Claudino, A. M., de Oliveira, I. R., Appolinario, J. C., Cordás, T. A., Duchesne, M., Sichieri, R. & Bacaltchuk, J. (2007): Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive behavioral therapy in binge eating disorder. The Journal of Clinical Psychiatry, 68, КСНУМКС-КСНУМКС.

Corsica, J. A. & Spring, B. J. (2008): Carbohydrate craving: A double-blind, placebo-controlled test of the self-medication hypothesis. Eating Behaviors, 9, КСНУМКС-КСНУМКС.

Cottone, P., Sabino, V., Steardo, L. & Zorrilla, E. P. (2008): Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Неуропсихофармакологија, КСНУМКС, КСНУМКС-КСНУМКС.

Davis, C. & Carter, J. C. (2009): Compulsive overeating as an addiction disorder: A review of theory and evidence. Аппетите, КСНУМКС, КСНУМКС-КСНУМКС.

Davis, C., Curtis, C., Levitan, R. D., Carter, J. C., Kaplan, A. S. & Kennedy, J. L. (2011): Evidence that ‘food addiction’ is a valid phenotype of obesity. Аппетите, КСНУМКС, КСНУМКС-КСНУМКС.

Davis, C. A., Levitan, R. D., Reid, C., Carter, J. C., Kaplan, A. S., Patte, K. A., King, N., Curtis, C. & Kennedy, J. L. (2009): Dopamine for “wanting” and opioids for “liking”: A comparison of obese adults with and without binge eating. Obesity, 17, КСНУМКС-КСНУМКС.

Dingemans, A. E., Bruna, M. J. & van Furth, E. F. (2002): Binge eating disorder: A review. The Journal of Obesity Related Metabolism Disorders, 26, КСНУМКС-КСНУМКС.

Drewnowski, A., Krahn, D. D., Demitrack, M. A., Nairn, K. & Gosnell, B. A. (1995): Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. The American Journal of Clinical Nutrition, 61, КСНУМКС-КСНУМКС.

Ferriter, C. & Ray, L. A. (2011): Binge eating and binge drinking: An integrative review. Eating Behaviors, 12, КСНУМКС-КСНУМКС.

Fortuna, J. L. (2012): The obesity epidemic and food addition: Clinical similarities to drug dependence. Јоурнал оф Псицхоацтиве Другс, 44(КСНУМКС), КСНУМКС-КСНУМКС.

Gadalla, T. & Piran, N. (2007): Co-occurrence of eating disorders and alcohol use disorders in women: A meta analysis. Archives of Women’s Mental Health, 10, КСНУМКС-КСНУМКС.

Gadde, K. M., Parker, C. B., Maner, L. G., Wagner, H. R., 2nd, Logue, E. J., Drezner, M. K. & Krishnan, K. R. (2001): Bupropion for weight loss: An investigation of efficacy and tolerability in overweight and obese women. Obesity Research, 9(КСНУМКС), КСНУМКС-КСНУМКС.

Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N. & Crews, F. T. (1999): Pharmacological treatment of alcohol dependence. The Journal of American Medical Association, 281, КСНУМКС-КСНУМКС.

Gearhardt, A. N., Corbin, W. R. & Brownell, K. D. (2009): Preliminary validation of the Yale Food Addiction Scale. Аппетите, КСНУМКС, КСНУМКС-КСНУМКС.

Gearhardt, A. N., White, M. A. & Potenza, M. N. (2011): Binge eating disorder and food addiction. Current Drug Abuse Review, 4, КСНУМКС-КСНУМКС.

Grant, J. E., Potenza, M. N., Weinstein, A. & Gorelick, D. A. (2010): Introduction to behavioral addictions. The American Journal of Drug and Alcohol Abuse, 36, КСНУМКС-КСНУМКС.

Greenway, F. L., Dunayevich, E., Tollefson, G., Erickson, J., Guttadauria, M., Fujioka, K. & Cowley, M. A. (2009): Comparison of combined bupropion and naltrexone therapy for obesity withmonotherpay and placebo. The Journal of Clinical Endocrinology and Metabolism, 94(КСНУМКС), КСНУМКС-КСНУМКС.

Grilo, C.M., White, M. A. & Masheb, R. M. (2009): DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder. The International Journal of Eating Disorders, 42, КСНУМКС-КСНУМКС.

Haltia, L. T., Rinne, J. O., Merisaari, H., Maguire, R. P., Savontaus, E., Helin, S., Någren, K. & Kaasinen, V. (2007): Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse, 61(КСНУМКС), КСНУМКС-КСНУМКС.

Hommer, R. E., Seo, D., Lacadie, C. M., Chaplin, T. M., Mayes, L. C., Sinha, R. & Potenza, M. N. (2012): Neural correlates of stress and favorite-food cue exposure in adolescents: A functional magnetic resonance imaging study. Human Brain Mapping, Epub ahead of print, doi: 10.1007/s11947-011-0773-6

Hudson, J. I., McElroy, S. L., Raymond, N. C., Crow, S., Keck, P. E., Jr., Carter, W. P., Mitchell, J. E., Strakowski, S. M., Pope, H. G., Jr., Coleman, B. S. & Jonas, J. M. (1998): Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled trial. Амерички часопис психијатрије, КСНУМКС, КСНУМКС-КСНУМКС.

Ifland, J. R., Preuss, H. G., Marcus, M. T., Rourke, K. M., Taylor, W. C., Burau, K., Jacobs, W. S., Kadish, W. & Manso, G. (2009): Refined food addiction: A classic substance use disorder. Medical Hypotheses, 72, КСНУМКС-КСНУМКС.

Jain, A. K., Kaplan, R. A., Gadde, K. M., Wadden, T. A., Allison, D. B., Brewer, E. R., Leadbetter, R. A., Richard, N., Haight, B., Jamerson, B. D., Buaron, K. S. & Metz, A. (2002): Bupropion SR vs placebo for weight loss in obese patients with depressive symptoms. Obesity Research, 10, КСНУМКС-КСНУМКС.

Johnson, P. M. & Kenny, P. J. (2010): Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Натуре Неуросциенце, КСНУМКС, КСНУМКС-КСНУМКС.

Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R. Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C. & Baker, T. B. (1999): A controlled trial of sustained released bupropion, a nicotine patch, or both for smoking cessation. Тхе Нев Енгланд Јоурнал оф Медицине, 340, КСНУМКС-КСНУМКС.

Kessler, R. C., Berglund, P. A., Chiu, W. T., Deitz, A. C., Hudson, J. I., Shahly, V., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Benjet, C., Bruffaerts, R., de Girolamo, G., de Graaf, R., Maria Haro, J., Kovess-Masfety, V., O’Neill, S., Posada-Villa, J., Sasu, C., Scott, K., Viana, M. C. & Xavier, M. (2013): The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Биолошка психијатрија, КСНУМКС, КСНУМКС-КСНУМКС.

King, A. C., Cao, D., Zhang, L. & O’Malley, S. S. (2013): Naltrexone reduction of long-term smoking cessation weight gain in women but not men: A randomized controlled trial. Биолошка психијатрија, КСНУМКС, КСНУМКС-КСНУМКС.

Koob, G. F. & Le Moal, M. (2001): Drug addiction, dysregulation of reward, and allostatis. Неуропсихофармакологија, КСНУМКС, КСНУМКС-КСНУМКС.

Lewinsohn, P. M., Seeley, J. R., Moerk, K. C. & Striegel-Moore, R. H. (2002): Gender differences in eating disorder symptoms in young adults. Међународни часопис за поремећаје у исхрани, 32, КСНУМКС-КСНУМКС.

Lilenfeld, L. R. R., Ringham, R., Kalarchian, M. A. & Marcus, M. D. (2008): A family history study of binge-eating disorder. Свеобухватна психијатрија, 49, КСНУМКС-КСНУМКС.

Luce, K. H., Engler, P. A. & Crowther, J. H. (2007): Eating disorders and alcohol use: Group differences in consumption rates and drinking motives. Eating Behaviors, 8, КСНУМКС-КСНУМКС.

Maldonado-Irizarry, C. S., Swanson, C. J. & Kelley, A. E. (1995): Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. Тхе Јоурнал оф Неуросциенце, 15, КСНУМКС-КСНУМКС.

Marrazzi, M. A., Markham, K. M., Kinzie, J. & Luby, E. D. (1995): Binge eating disorder: Response to naltrexone. The International Journal of Obesity and Related Metabolism Disorders, 19(КСНУМКС), КСНУМКС-КСНУМКС.

McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Jr., Rosenthal, N. R., Karim, M. R., Kamin, M. & Hudson, J. I. (2003): Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. Амерички часопис психијатрије, КСНУМКС, КСНУМКС-КСНУМКС.

McElroy, S. L., Casuto, L. S., Nelson, E. B., Lake, K. A., Soutullo, C. A., Keck, P. E., Jr. & Hudson, J. I. (2000): Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Амерички часопис психијатрије, КСНУМКС, КСНУМКС-КСНУМКС.

McElroy, S. L., Guerdjikova, A. I., Mori, N. & O’Melia, A. M. (2012): Pharmacological management of binge eating disorder: Current and emerging treatment options. Therapeutics and Clinical Risk Management, 8, КСНУМКС-КСНУМКС.

McElroy, S. L., Guerdjikova, A. I., Winstanley, E. L., O’Melia, A. M., Mori, N., McCoy, J., Keck, P. E. & Hudson, J. I. (2011): Acamprosate in the treatment of binge eating disorder: A placebo-controlled trial. The International Journal of Eating Disorders, 44, КСНУМКС-КСНУМКС.

McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., Rosenthal, N. R. & Topiramate Binge Eating Disorder Research Group (2007): Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Биолошка психијатрија, КСНУМКС, КСНУМКС-КСНУМКС.

Merikangas, K. R. & McClair, V. L. (2012): Epidemiology of substance use disorder. Human Genetics, 131, КСНУМКС-КСНУМКС.

Meyer, F. (2008): Alleviation of both binge eating and sexual dysfunction with naltrexone. The Journal of Clinical Psychopharmacology, 28(КСНУМКС), КСНУМКС-КСНУМКС.

Miller, P. M., Book, S. W. & Stewart, S. H. (2011): Medical treatment of alcohol dependence: A systematic review. The International Journal of Psychiatry Medicine, 42(КСНУМКС), КСНУМКС-КСНУМКС.

Myers, K.M., Carlezon, W. A., Jr. & Davis, M. (2011): Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Неуропсихофармакологија, КСНУМКС, КСНУМКС-КСНУМКС.

Neumeister, A., Winkler, A. & Wober-Bingol, C. (1999): Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. Амерички часопис психијатрије, КСНУМКС(КСНУМКС), КСНУМКС.

Rabiner, E. A., Beaver, J., Makwana, A., Searle, G., Long C., Nathan, P. J., Newbould, R. D., Howard, J., Miller, S. R., Bush, M. A., Hill, S., Reiley, R., Passchier, J., Gunn, R. N., Matthews, P. M. & Bullmore, E. T. (2011): Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Молекуларна психијатрија, КСНУМКС, КСНУМКС-КСНУМКС.

Schaechter, J. D. & Wurtman, R. J. (1990): Serotonin release varies with brain tryptophan levels. Истраживање мозга, 532, КСНУМКС-КСНУМКС.

Sheng, L. X., Tang, Y. L., Jiang, Z. N., Yao, C. H., Gao, J. Y., Xu, G. Z. & Tong, X. Y. (2013): Sustained-release bupropion for smoking cessation in Chinese sample: A double-blind, placebo-controlled, randomized trial. Nicotine & Tobacco Research, 15(КСНУМКС), КСНУМКС-КСНУМКС.

Sim, L. A., McAlpine, D. E., Grothe, K. B., Himes, S. M., Cockerill, R. G. & Clark, M. M. (2010): Identification and treatment of eating disorders in the primary care setting. Mayo Clinic Proceedings, 85, КСНУМКС-КСНУМКС.

Smith, D. G. & Robbins, T. W. (2013): The neurobiological under-pinnings of obesity and binge eating: A rationale for adopting the food addiction model. Биолошка психијатрија, КСНУМКС(КСНУМКС), КСНУМКС-КСНУМКС.

Snyder, J. L. & Bowers, T. G. (2008): The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: A relative benefits analysis of randomized controlled trials. The American Journal of Drug and Alcohol Abuse, 34, КСНУМКС-КСНУМКС.

Spring, B., Wurtman, J., Gleason, R. & Kessler, K. (1991): Weight gain and withdrawal symptoms after smoking cessation: A preventive intervention using d-fenfluramine. Health Psychology, 10, КСНУМКС-КСНУМКС.

Tanofsky-Kraff, M., Bulik, C. M., Marcus, M. D., Striegel, R. H., Wilfley, D. E., Wonderlich, S. A. & Hudson, J. I. (2013): Binge eating disorder: The next generation of research. The International Journal of Eating Disorders, 46, КСНУМКС-КСНУМКС.

Tata, A. L. & Kockler, D. R. (2006): Topiramate for binge-eating disorder associated with obesity. The Annals of Pharmaco-therapy, 40(КСНУМКС), КСНУМКС-КСНУМКС.

Thanos, P. K., Bermeo, C., Wang G. J. & Volkow, N. D. (2011): Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats. Behavioural Brain Research, 217, КСНУМКС-КСНУМКС.

van den Brink, W. (2012): Evidence-based pharmacological treatment of substance use disorder and pathological gambling. Current Drug Abuse Review, 5, КСНУМКС-КСНУМКС.

Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Thanos, P. K., Logan, J., Alexoff, D., Ding, Y. S., Wong, C., Ma, Y. & Pradhan, K. (2008): Low dopamine striatal D2 receptors are associated with prefrontalmetabolism in obese subjects: Possible contributing factors. Neuroimage, 42(КСНУМКС), КСНУМКС-КСНУМКС.

Volkow, N. D., Wang, G. J., Tomasi, D. & Baler, R. D. (2013): Obesity and addiction: Neurobiological overlaps. Obesity Review, 14, КСНУМКС-КСНУМКС.

Wang, G. J., Geliebter, A., Volkow, N. D., Telang, F. W., Logan, J., Jayne, M. C., Galanti, K., Selig, P. A., Han, H., Zhu, W., Wong, C. T. & Fowler, J. S. (2011): Enhanced striatal dopamine released during food stimulation in binge eating disorder. Obesity, 19, КСНУМКС-КСНУМКС.

Wang, G. J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusil, N. & Fowler, J. S. (2001): Brain dopamine and obesity. Ланцет, КСНУМКС, КСНУМКС-КСНУМКС.

Wang, G. J., Volkow, N. D., Thanos, P. K. & Fowler, J. S. (2004): Similarity between obesity and drug addiction as assessed by neurofunctional imagining: A concept review. Journal of Addictive Disorders, 23, КСНУМКС-КСНУМКС.

White, M. A. & Grilo, C. M. (2013): Bupropion for overweight women with binge-eating disorder: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 74(КСНУМКС), КСНУМКС-КСНУМКС.

Wise, R. A. (2004): Rewards wanted: Molecular mechanisms of motivation. Discovery Medicine, 4, КСНУМКС-КСНУМКС.

Zhang, M., Gosnell, B. A. & Kelley, A. E. (1998): Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics, 285, КСНУМКС-КСНУМКС.

Ziauddeen, H., Farooqi, I. S. & Fletcher, P. C. (2012): Obesity and the brain: How convincing is the addiction model. Природа Прегледи Неуросциенце, КСНУМКС, КСНУМКС-КСНУМКС.

Ziauddeen, H. & Fletcher, P. C. (2012): Is food addiction a valid and useful concept? Прегледи гојазности, 14, КСНУМКС-КСНУМКС.